Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease

NCT01527916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

438

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: placebo
DRUG: donepezil
DRUG: ABT-126

Sponsor

AbbVie (prior sponsor, Abbott)